Related by context. All words. (Click for frequent words.) 79 Prolongs Survival 79 Clinical Trial Results 78 Improves Survival 77 Unfractionated Heparin 77 Efficacious 77 Patients Treated With 77 Meets Primary Endpoint 77 Knee Osteoarthritis 77 Well Tolerated 77 Statistically Significant 77 Anti Tumor 76 Drug Candidate 76 Previously Treated 76 Survival Benefit 76 Single Dose 76 Investigational Compound 76 Tumor Growth 76 Osteoporosis Drug 76 Antitumor Activity 76 Disease Progression 76 Patients Undergoing 76 FDA Okays 75 Teva Provides Update 75 Demonstrates Significant 75 Cholesterol Lowering Drug 75 Statin Therapy 75 Combination Therapy 75 Blood Pressure Drug 75 Fracture Risk 75 Rheumatoid Arthritis Patients 75 Novel Oral 75 FDA Approvals 75 Gout Drug 75 Significantly Improved 75 Kidney Transplant Patients 75 Prophylactic Treatment 75 Extended Release 75 Monotherapy 75 Renal Cell Carcinoma 75 Appears Safe 75 Improve Survival 75 Hypertensive Patients 74 Patients Receiving 74 Adjuvant Treatment 74 Phase IIb Trial 74 Inhaled Corticosteroids 74 Treating Chronic 74 Fixed Dose 74 Breast Cancer Recurrence 74 Combination Treatment 74 Demonstrates Potent 74 Elderly Patients 74 Patients Treated 74 Heart Failure Patients 74 Pooled Analysis 74 JAK Inhibitor 74 Rheumatoid Arthritis Drug 74 Drug Shows Promise 74 Generic Versions 74 Submits NDA 74 Adjuvant Chemotherapy 74 Shows Efficacy 74 Improves Outcomes 74 Study Evaluating 74 Beta Blocker 74 Pediatric Patients 74 Postmenopausal Women 74 Study Showed 74 Overactive Bladder 73 Phase III Clinical Trial 73 Investigational Agent 73 Benign Prostatic Hyperplasia 73 Kidney Function 73 Demonstrates Efficacy 73 Hormone Therapy 73 Fungal Infections 73 Receives Orphan Drug Designation 73 Present Preclinical Data 73 Epilepsy Drug 73 Previously Untreated 73 Phase 2a Clinical Trial 73 IND Application 73 Lung Cancer Drug 73 Rotavirus Vaccine 73 Antifungal 73 Relapsing Multiple Sclerosis 73 Transdermal Patch 73 Novel Antibiotic 73 Long Term Efficacy 73 Demonstrated Significant 73 Showed Significant 73 Demonstrates Positive 73 Advanced Colorectal Cancer 73 Adjuvant Therapy 73 Skeletal Muscle 73 Advanced Prostate Cancer 73 Improved Survival 73 Prostate Cancer Patients 73 Recombinant Human 73 Preclinical Data 73 Radiation Dose 73 Cardiovascular Events 73 Orally Active 73 Osteoporosis Drugs 73 Novel Inhibitor 73 Clinical Outcome 73 Presents Preclinical Data 73 Treatment Reduces 73 Shows Promising 73 Meta Analysis 73 Aliskiren 73 Prostate Cancer Vaccine 73 Data Suggest 73 Completes Patient Enrollment 73 Cholesterol Drug 73 Is Well Tolerated 73 Generic Version 73 Significantly Reduces 73 Oral Fingolimod 73 Clinical Efficacy 73 Treatment Regimen 72 Lowers Risk 72 Protease Inhibitor 72 Postmenopausal Osteoporosis 72 Arthritis Drug 72 Phase III Trial 72 Enlarged Prostate 72 Significantly Reduced 72 Effectively Treats 72 Anemia Drug 72 Smooth Muscle 72 Shown Effective 72 Phase 2b Clinical Trial 72 FDA Accepts 72 Proves Effective 72 Drug Fails 72 Tyrosine Kinase Inhibitor 72 Melphalan 72 Versus Placebo 72 Bone Metastases 72 ACE Inhibitors 72 Fondaparinux 72 Breast Cancer Cells 72 Sustained Release 72 Anti Tumor Activity 72 NDA Submission 72 Oral Formulation 72 Shows Promise 72 Completes Enrollment 72 Anti Inflammatory Drug 72 Medoxomil 72 Effective Than 72 Inhibits 72 Mouse Model 72 Minimally Invasive Treatment 72 Investigational Drug 72 Blood Thinner 72 Complicated Skin 72 Resistant Hypertension 72 Chemoradiation 72 Mg Usa 72 Cholesterol Lowering 72 Reduced Risk 72 Antitumor 72 Cyclophosphamide 72 Capecitabine 72 See CLINICAL PHARMACOLOGY 72 FDA Clears 72 Plus Ribavirin 72 Advanced Melanoma 72 Phase 2b Study 72 Attenuates 72 Small Molecule 72 Plaque Psoriasis 72 Anticancer Drug 72 Bivalirudin 72 Files IND 72 Dose Escalation 72 Posaconazole 72 Reduces Pain 72 Tiotropium 72 Receptor Antagonist 72 Novel Mechanism 72 Lung Cancer Patients 72 Expanded Indication 72 Treated Patients 72 Therapy Reduces 72 Artery Disease 72 Obese Patients 72 Beneficial Effects 72 Controlled Trial 72 Enoxaparin 72 Hormonal Therapy 72 Proven Effective 72 Reduces Risk 72 Pre Cancerous 72 Lung Cancer Survival 72 FDA Panel Recommends 72 Osteoporosis Treatment 71 Kinase Inhibitor 71 Levels Linked 71 Bosutinib 71 Lupus Drug 71 Neoadjuvant Chemotherapy 71 Increases Risk 71 Extended Release Formulation 71 Menopausal Symptoms 71 Pharmacokinetic Study 71 Randomized Double Blind 71 Double Blind Randomized 71 Clinical Trial Evaluating 71 Localized Prostate Cancer 71 Contrast Agents 71 Demonstrates Potential 71 Increased Mortality 71 Infected Patients 71 Peginterferon Alfa 2a 71 Therapy Improves 71 Anti Inflammatory 71 Breast Tumors 71 Nicotine Vaccine 71 Non Inferiority 71 Anticancer Activity 71 Induces 71 Investigational Treatment 71 Myeloma Patients 71 Erectile Dysfunction Drug 71 Breast Cancer Patients 71 Cyclooxygenase 2 71 Diabetic Patients 71 Cancer Cells 71 Antiplatelet 71 Topical Treatment 71 Treatment Naïve 71 Peginterferon 71 Protease Inhibitors 71 Bare Metal Stents 71 Phase III Trials 71 Cholesterol Drugs 71 Interferon Beta 71 Maleate 71 Prostate Cancer Treatment 71 Phospholipase A2 71 Study Demonstrates 71 Psoriasis Drug 71 Endometrial Cancer 71 Hemodialysis Patients 71 Radiofrequency Ablation 71 Osteoarthritis Pain 71 Anticoagulant 71 Confirmatory Phase 71 Shows Promise Against 71 Renal Function 71 Glucose Levels 71 Cancer Recurrence 71 Novel Compound 71 Vaginal Gel 71 Randomized Double blind 71 Prognostic Factors 71 Fluorouracil 71 Metastatic Melanoma 71 Node Positive 71 Chemotherapy Regimen 71 Prospective Randomized 71 Initiate Clinical Trial 71 Drug Eluting 71 Drug Prevents 71 Tumor Cells 71 Renal Impairment 71 Hip Fractures 71 Pivotal Phase III 71 Therapeutic Potential 71 Chronic Hepatitis C 71 Osteoarthritis Patients 71 Antipsychotic 70 Drug Coated Stent 70 Secondary Hyperparathyroidism 70 Subgroup Analysis 70 Dose Response 70 Combo Therapy 70 Placebo Controlled Trial 70 Cinacalcet 70 Preclinical Study 70 Tolerability 70 Fewer Side Effects 70 Percutaneous Tibial Nerve Stimulation 70 Orthostatic Hypotension 70 Inflammatory Markers 70 Hypercholesterolemia 70 Lung Cancer Trial 70 Urinary Incontinence 70 Pulmonary Arterial Hypertension 70 Epoetin Alfa 70 Receives Approvable Letter 70 Desvenlafaxine Succinate 70 Controlled Study 70 Transdermal Delivery 70 Epidermal Growth Factor Receptor 70 Severe Sepsis 70 Initiates Clinical Trials 70 Insulin Glargine 70 Clinically Tested 70 Zoledronic Acid 70 Tumor Targeting 70 Hormone Refractory Prostate Cancer 70 Breast Cancer Treatment 70 Long Term Survival 70 Improve Outcomes 70 HER2 Positive 70 Mg Uk 70 Cholesterol Lowering Drugs 70 Metastatic Prostate Cancer 70 Statin Drugs 70 Unresectable 70 Allergic Rhinitis 70 Prostate Biopsy 70 Lowers Blood Pressure 70 Slows Progression 70 Myelodysplastic Syndromes 70 Demonstrates Statistically Significant 70 Critically Ill Patients 70 Adverse Effects 70 Colorectal Cancer Patients 70 Mylan Receives Approval 70 Pharmacodynamics 70 Drug Combo 70 Epilepsy Drugs 70 Dose Ranging Study 70 Calcium Vitamin D 70 Signaling Pathway 70 Refractory Hodgkin Lymphoma 70 Significantly Improves 70 Corticosteroid 70 Radical Prostatectomy 70 Prognostic Significance 70 Oral Mucositis 70 Phase 2b Trial 70 Diet Pill 70 Initiates Clinical Trial 70 Platelet Inhibition 70 Hsp# Inhibitor 70 Receptor Antagonists 70 Gastric Cancer 70 Clinical Trial Data 70 Gene Variant 70 Non Responders 70 Pivotal Study 70 Heartburn Drugs 70 Premenopausal Women 70 Newly Diagnosed Multiple Myeloma 70 Atopic Dermatitis 70 Hormone Receptor Positive 70 Treatment Naïve Patients 70 Non Invasive 70 Uric Acid 70 Schizophrenia Treatment 70 Ranolazine 70 Antiviral Activity 70 Less Invasive 70 Therapeutic Efficacy 70 Breast Cancers 70 Bone Mineral Density 70 Total Knee Arthroplasty 70 Neoadjuvant 70 Patent Covering 70 Pivotal Phase 70 Anthracycline 70 Angiogenic 70 Novel Treatments 70 Antidepressant Drug 70 Disease Modifying 70 Replacement Therapy 70 Migraine Drug 70 Metastatic Colorectal Cancer 70 Granted Orphan Drug 70 Synthetic Peptide 70 Interferon Alfa 70 Randomized Double Blind Placebo 70 Asthma Treatment 70 Testosterone Patch 70 AnaSpec Introduces 70 Phase IIa Clinical Trial 70 Colorectal Cancer Risk 70 Hepatitis C Genotype 70 Androgen Deprivation Therapy 70 Schizophrenia Drug 70 Carotid Stenting 70 Pegylated 70 Weight Loss Drug 69 Nucleoside 69 Non Invasive Treatment 69 Tablet Formulation 69 Cannabinoid 69 Placebo Controlled Study 69 Electrical Stimulation 69 Cardiotoxicity 69 Diabetic Nephropathy 69 Regenerative Cells 69 Left Ventricular 69 Estrogen Therapy 69 Lipid Levels 69 Double Blind Placebo 69 Vitro Activity 69 Antipsychotic Drug 69 Migraine Headaches 69 Study Proves 69 Anti Angiogenic 69 Liver Failure 69 Invasive Breast Cancer 69 HER2 Positive Breast Cancer 69 Regimens 69 Gets FDA Clearance 69 Clinically Proven 69 Initiates Phase III 69 Successfully Completes Phase 69 Antiplatelet Therapy 69 Receptor Agonist 69 Bladder Cancer 69 Drug Resistant 69 Cholesterol Levels 69 Ovarian Cancer Risk 69 Diuretic 69 Patients Suffering 69 Randomized Clinical Trial 69 Initiates Clinical 69 Bisphosphonate 69 Gene Mutation 69 FDA Approves 69 Thrombotic 69 Bevacizumab 69 Intracranial Aneurysms 69 Newly Diagnosed 69 Sustained Reduction 69 5 Fluorouracil 69 Receives FDA Clearance 69 Prognostic Value 69 Develop Novel 69 Antiangiogenic 69 Autologous Stem Cell Transplantation 69 ORLive Presents 69 Myocardial Ischemia 69 Adjunctive Therapy 69 Gene Variants 69 Immune Responses 69 Dasatinib 69 Cilostazol 69 Diabetic Foot Ulcer 69 Effective Treatments 69 Blood Flow 69 Pivotal Trial 69 Potentially Fatal 69 Stomach Cancer 69 Suppresses 69 Novel Anti Inflammatory 69 FDA Warns Against 69 Advanced Renal Cell 69 Capsules CII 69 Acute Pancreatitis 69 Higher Doses 69 Progenitor Cells 69 Phase 2a Trial 69 Hematological Cancers 69 Primary Hypercholesterolemia 69 Pain Relievers 69 Abciximab 69 Acute Ischemic Stroke 69 Impairs 69 Adenoma 69 Chronic Sinusitis 69 Long Lasting 69 Commonly Used 69 Anemia Drugs 69 Glucose Control 69 Invasive Fungal Infections 69 Contrast Enhanced 69 Aurora Kinase 69 Lower Blood Pressure 69 Trial Evaluating 69 MR Angiography 69 Cardiac Function 69 Immunomedics Announces 69 Sirolimus Eluting Stent 69 Slow Progression 69 Lanthanum Carbonate 69 Intravenous Formulation 69 Positive Opinion 69 Vildagliptin 69 Diabetic Kidney Disease 69 RNAi Therapeutic 69 Long Term Outcomes 69 Post Operative 69 Endovascular Treatment 69 Phase IIb Clinical Trial 69 Tigecycline 69 Radiofrequency Ablation RFA 69 Gene Variation 69 Contrast Agent 69 Receives SFDA Approval 69 Venous Thromboembolism 69 Diabetic Foot Ulcers 69 Pegylated Liposomal Doxorubicin 69 Metastatic Cancer 69 Fast Track Status 69 Treatment Naive Patients 69 Liver Injury 69 Antigen Specific 69 Inhaled Insulin 69 Brain Metastases 69 Thyroid Hormone 69 Tumor Progression 69 Carboplatin Paclitaxel 69 Clinical Study Shows 69 Hepatitis C Patients 69 Irinotecan 69 Menopausal Women 69 Oral Calcitonin 69 Leukemia Cells 69 Diabetic Neuropathy 69 Hyperlipidemia 69 Chemotherapeutic Agents 68 PDUFA Date 68 Severe Acne 68 Gene Linked 68 Carcinomas 68 Eluting Stent 68 Blood Vessels 68 Inhaled Nitric Oxide 68 Pain Medications 68 Dehydrogenase 68 HDAC Inhibitor 68 Silicone Breast Implants 68 Kidney Transplant Recipients 68 Randomized Trials 68 Initiate Phase 68 Migraine Pain 68 Liver Damage 68 Crit Rev 68 Advanced Ovarian Cancer 68 Immune Cells 68 Fluticasone 68 Initiate Phase III 68 Initiates Enrollment 68 Immunomodulatory 68 Hormone Replacement 68 Treatment Naive HIV 68 FDA Clearance 68 Cancer Treatments 68 Chemotherapy Induced 68 II Clinical Trial 68 Ovarian Cancers 68 Polymerase Inhibitor 68 Testosterone Gel 68 R lenalidomide 68 Novel Therapeutic 68 J Am Coll 68 Beta Blockers 68 Conjugated 68 Lung Cancers 68 Receives Positive Opinion 68 Molecular Mechanism 68 Patient Enrollment 68 Blood Clot Risk 68 Shingles Vaccine 68 Potent Antiviral Activity 68 Demonstrate Significant 68 Prove Effective 68 Sex Hormones 68 Prevent Stroke 68 Inflammatory Arthritis 68 Painkiller Abuse 68 Male Contraceptive 68 Blood Thinning 68 Announces FDA Clearance 68 Adjunctive 68 Oral Anticoagulant 68 Combination Clinical Trial 68 Intravitreal 68 Immunotherapeutic 68 Weight Loss Supplement 68 Randomized Study 68 Pafuramidine 68 Enalapril 68 Chronic Heart Failure 68 Immunogenic 68 Study Shows Benefits 68 Patients Enrolled 68 Viral Load 68 Ovarian Cancer Patients 68 Blood Clots 68 Efficacy Trial 68 Endothelial Function 68 Clinical Evaluation 68 Milestone Payment 68 Bortezomib 68 Protein Linked 68 Sirolimus Eluting 68 Novel Method 68 Cypher Sirolimus 68 Nilotinib 68 Esomeprazole 68 Oral Cavity 68 Bazedoxifene 68 Metastatic Renal Cell Carcinoma 68 Zoloft sertraline 68 Recurrent Breast Cancer 68 Anticancer Agent 68 Dendritic Cells 68 Oral Spray 68 Stem Cell Treatment 68 HCV Protease Inhibitor 68 Haemophilus b Conjugate 68 Achieves Primary Endpoint 68 Combination REOLYSIN R 68 Subcutaneous 68 Significant Improvements 68 Neuroprotective Effects 68 Genes Linked 68 Factor Receptor 68 Ischemic 68 Glatiramer Acetate 68 Monoclonal Antibody 68 Thiazolidinediones 68 Dose Finding 68 Anticancer Drugs 68 Allergic Reactions 68 Proton Pump Inhibitors 68 Immunosuppression 68 J Clin 68 Stent Coating 68 Mimetics 68 Genital Herpes 68 Spinal Fusion 68 Treatment Resistant 68 Relieve Pain 68 Parathyroid Hormone 68 Venous Thrombosis 68 Blood Clotting 68 Gemcitabine 68 Boosts Survival 68 Pioglitazone 68 Molecular Weight Heparin 68 Multiple Myeloma Patients 68 Cardiovascular Disease Risk 68 Randomized Phase 68 Liver Transplant Patients 68 Aggressive Prostate Cancer 68 Soft Tissue Sarcoma 68 Oral Contraceptive 68 Unmet Medical 68 Drug Coated Stents 68 Lenalidomide 68 Preterm Delivery 68 Lowers Cholesterol 68 Carotid Artery Stenting 68 Respiratory Virus 68 Interferon Alpha 68 Pharmacokinetics PK 68 Platelet Function 68 Premature Infants 68 dual endothelin receptor antagonist 68 Radioimmunotherapy 68 Interferon Gamma 68 Receives Orphan Drug 68 Vaccine Adjuvant 67 Relapsed Refractory 67 Weight Loss Pill 67 Antiviral Therapy 67 Stress Urinary Incontinence 67 Androgen Receptor 67 Antidepressants Linked 67 Refractory Angina 67 Hepatic Encephalopathy 67 TNF Blockers 67 Increased Risk 67 Lupus Nephritis 67 Fulvestrant 67 Cognitive Impairment 67 Valsartan 67 Paclitaxel Carboplatin 67 Shows Statistically Significant 67 Serious Side Effects 67 Calcitonin 67 Generic Version Of 67 Conjugate 67 Minimally Invasive Procedure 67 Cell Adhesion 67 BioElectronics Announces 67 Tezampanel 67 Prostatic 67 Tesamorelin 67 Hernia Repair 67 Reductase 67 Squamous Cell Carcinoma 67 First Patient Dosed 67 Randomized Controlled Trials 67 Pulmonary Artery 67 Fibromyalgia Pain 67 Lamotrigine 67 Aortic Stenosis 67 Acne Drug 67 Lung Cancer Risk 67 Study Casts Doubt 67 Signaling Pathways 67 Demonstrates Sustained 67 Pneumococcal Vaccine 67 Randomized Clinical Trials 67 Partial Onset Seizures 67 Protein Involved 67 Fluconazole 67 Phase 1b Clinical Trial 67 Anti Clotting Drug 67 Lubiprostone 67 JAK2 Inhibitor 67 Stent Thrombosis 67 NAVISTAR R 67 Breast Cancer Risk 67 Embolization 67 Pegylated Interferon 67 Protein Synthesis 67 Estrogen Receptor 67 Presents Positive 67 Aromatase Inhibitors 67 Relapsing Remitting Multiple Sclerosis 67 TNF Tumor Necrosis Factor 67 First Patient Treated 67 Bipolar Depression 67 Lung Tumors 67 Decitabine 67 Metabolic Disorder 67 Prolongs Life 67 ADHD Medication 67 Prostate Tumors 67 Visceral Fat 67 Bare Metal Stent 67 Potent Anti 67 Clostridium difficile Infection 67 Insulin Resistance 67 Retinoic Acid 67 Blood Pressure Lowering 67 Genes Involved 67 GRAS Status 67 Systemic Delivery 67 Low Doses 67 Cytarabine 67 Tipranavir 67 Breast Cancer Stem Cells 67 Skin Lesions 67 Montelukast 67 Generic Protonix 67 Abiraterone Acetate 67 Gastrointestinal Disorders 67 Preterm Labor 67 Reduces Mortality 67 Excessive Sweating 67 Therapeutic Antibody 67 Bioresorbable 67 Predict Risk 67 Adefovir 67 Itraconazole 67 Hepatitis B Vaccine 67 CYP#A# CYP#D# 67 Obesity Linked 67 Ultrasound Guided 67 Panic Disorder 67 Immunosuppressant 67 Migraine Treatment 67 Contraindications 67 Septic Shock 67 Tumor Response 67 Successfully Treated 67 Lung Cancer Treatment 67 C Reactive Protein 67 Muscle Wasting 67 Peptic Ulcer 67 Budesonide 67 Chronic Hepatitis B 67 Allogeneic 67 Mesalamine 67 Low Density Lipoprotein Cholesterol 67 PRN FDA Approves 67 Lipid Lowering 67 Heart Stents 67 Hemoglobin Levels 67 Advanced Pancreatic Cancer 67 Catheter Ablation 67 Imaging Technique 67 Hepatocellular Carcinoma 67 Embolic Protection 67 Curr Opin 67 Hepatitis C Infection 67 Announces Tentative Approval 67 Coronary Angiography 67 Cytotoxicity 67 Testosterone Levels 67 Cocaine Addiction 67 Aortic Valve 67 Chromium Picolinate 67 Venlafaxine 67 Renal Cancer 67 Castration Resistant Prostate Cancer 67 Liposomal 67 Tumor Cell 67 Eases Pain 67 Coronary Arteries 67 Menstrual Cramps 67 Desloratadine 67 Peginterferon alfa 2b 67 Genes Predict 67 Prevent Breast Cancer 67 Radiation Induced 67 Dose Escalation Study 67 Breast Density 67 Cutaneous T 67 Viral Suppression 67 Commonly Prescribed 67 Seasonal Allergic Rhinitis 67 Antithrombin 67 Peripheral Arterial 67 Dual Antiplatelet Therapy 67 Nebulized 67 Virus Infection 67 Analogs 67 Randomized Placebo Controlled Trial 67 Liver Toxicity 67 Ziprasidone 67 Colorectal Adenomas 67 Chronic Renal Failure 67 Potent Inhibitor 67 Predict Response 67 Randomized Comparison 67 Ecallantide 67 Anti Inflammatory Drugs 67 Blood Glucose Levels 67 Hospital Acquired Pneumonia 67 Stronger Warnings 67 Prevent Prostate Cancer 67 Valve Replacement 67 Cardiovascular Outcomes 67 Inflammatory Response 67 Psoriasis Patients 67 Sapacitabine 67 Female Sexual Arousal 66 Significant Improvement 66 Analgesic 66 Treating Heart Failure 66 Stem Cell Transplants 66 Fluticasone Propionate 66 Breast Cancer Metastasis 66 Potency 66 Soy Isoflavones 66 Malignant Glioma 66 IND Filing 66 Cell Proliferation 66 Circulating Tumor Cells 66 CHMP Opinion 66 Advanced Gastric Cancer 66 Statistical Significance 66 Enzyme Replacement Therapy 66 Test Detects 66 Avian Flu Vaccine 66 Denufosol 66 Preterm Infants 66 Genetic Mutation 66 Approvable 66 Insulin Sensitivity 66 Study Shows Significant 66 Danazol 66 Brain Cells 66 Chronic Lymphocytic Leukemia 66 Gum Disease 66 Malaria Vaccine 66 Basal Insulin 66 Inflammatory Disease 66 Oral Insulin 66 Tacrolimus 66 Cognitive Function 66 Glucocorticoid 66 Embolic 66 Intracerebral Hemorrhage 66 Vitamin D Linked 66 Lymph Node 66 Subtypes 66 FDA APPROVES 66 Patents Covering 66 Drug Interactions 66 Inhibit 66 Bosentan 66 Stent Implantation 66 Treating Depression 66 Alternative Treatments 66 Novel Protein 66 Iron Deficiency 66 Taxane 66 Bronchodilator 66 Mycophenolate Mofetil 66 Treatment Experienced 66 Spectrum Pharmaceuticals Announces 66 Eszopiclone 66 COPD Exacerbations 66 Launches Generic Version 66 Drug Eluting Stents 66 Somatostatin 66 Acne Scars 66 Gastric Ulcers 66 Cervical Spine 66 Interferon beta 1a 66 Severe Chronic Pain 66 Anti TNF 66 Topical Cream 66 Antipsychotic Drugs 66 CT Angiography 66 Renal Anemia 66 First Patient Enrolled 66 Arterial Disease 66 Blocked Arteries 66 Autoimmune Disease 66 Risedronate 66 Treatment Shows Promise 66 Targeted Therapies 66 Stress Incontinence 66 Initiates Phase II 66 Kinase Inhibitors 66 Renal Cell Cancer 66 Moderate Drinking 66 Cardiogenic Shock 66 Certain Cancers 66 Chronic Inflammation 66 Endothelial Cells 66 Treatment Naive 66 External Beam 66 Parenteral Nutrition 66 Antibiotic Use 66 Atypical Antipsychotic 66 TNF Alpha 66 Eur J 66 Rectal Cancer 66 Epoetin 66 Liver Tumors 66 Could Prevent 66 Recommends Approval 66 Prostate Cancer Survival 66 Renal Artery 66 Surgical Treatment 66 Abdominal Fat 66 Fixed Dose Combination 66 Blood Pressure Reduction 66 Erlotinib 66 TO AVOID PREGNANCY WHILE 66 Treatment Regimens 66 Antiviral Drugs 66 Acute Migraine 66 Tumor Suppressor 66 Thrombus 66 Genital Warts 66 Metastases 66 Amino Acid 66 Darbepoetin Alfa 66 Analytical Tool 66 Kidney Failure 66 Coronary Stents 66 Novel Compounds 66 Intracerebral 66 Am J Clin 66 Investigational Oral 66 RNAi Therapeutics 66 Holds Promise 66 Amniotic Fluid 66 Maribavir 66 Cognitive Decline 66 Intravascular 66 Corneal Transplant 66 Presents Preclinical 66 Anticoagulants 66 Stent Placement 66 FDA Approves Drug 66 Prostate Cancer Progression 66 Golimumab 66 Inhaled Steroids 66 Mucosal 66 Oligonucleotides 66 Symptom Relief 66 Experimental Vaccine 66 Zorbtive TM 66 Spinal Fluid 66 Inflammatory Diseases 66 Announces Publication 66 Myocardial Perfusion Imaging 66 Significant Efficacy 66 methylnaltrexone bromide 66 Glufosfamide 66 Therapeutic Vaccine 66 Indomethacin 66 STELARA TM 66 Reduce Risk 66 Chemotherapeutic 66 Sangamo BioSciences Announces 66 Randomized Phase II 66 Serious Infections 66 Immune Cell